Publications by authors named "A Pluzanski"

Article Synopsis
  • * A pooled analysis of clinical trials showed that patients receiving this combination treatment had better overall survival (17.4 months) compared to those receiving chemotherapy alone (11.3 months) at a median follow-up of 73.7 months.
  • * The combination treatment also resulted in higher progression-free survival and objective response rates without new safety concerns, making it a promising first-line option for hard-to-treat NSCLC cases.
View Article and Find Full Text PDF

We investigated association between skin adverse events (AEs) and efficacy with dacomitinib in patients with -positive non-small-cell lung cancer (NSCLC). analyses from ARCHER 1050 evaluated efficacy in patients who did and did not experience grade ≥2 skin AEs with dacomitinib. Landmark analyses were performed at 3 and 6 months.

View Article and Find Full Text PDF
Article Synopsis
  • Many patients with advanced cancer, like tracheal cancers, can't be cured, making palliative care vital.
  • Existing studies mostly look at palliative care as part of broader cancer treatments and don't focus solely on tracheal tumors.
  • This review presents the first detailed clinical guidelines for palliative treatment specifically for tracheal cancer, addressing unique challenges not covered by other cancer treatment guidelines.
View Article and Find Full Text PDF
Article Synopsis
  • A retrospective study assessed the effectiveness of crizotinib versus newer ROS1-targeted therapies in patients with advanced non-small-cell lung cancer (NSCLC).
  • Among 49 ROS1-expressing patients, those treated with newer agents like entrectinib and repotrectinib had higher response and disease control rates compared to those treated with crizotinib.
  • Despite crizotinib showing comparable results, the newer therapies demonstrated longer median progression-free survival, highlighting the potential benefits of newer treatment options.
View Article and Find Full Text PDF

Pulmonary benign metastasizing leiomyoma (PBML) is a rare condition characterized by the spread of uterine leiomyomas to the lungs, typically observed in premenopausal women with a history of hysterectomy or myomectomy. This report presents a unique case of a postmenopausal woman, aged 65, that emphasizes the clinical, radiological, histologic, and immunohistochemical aspects of the disease. On presentation, the patient suffered from severe pain.

View Article and Find Full Text PDF